Introduction: We compared rates of risk reducing mastectomies (RRM) in patients with breast cancer (BC)-related pathogenic variants.
Methods: Female patients ages ≥18 with a BC-related pathogenic variant, without a concurrent or prior BC diagnosis, were identified from a single academic center's database. Patients were stratified by BRCA mutations, high penetrance mutations (HPM), and moderate penetrance mutations (MPM). Race and ethnicity were classified as non-Hispanic White (NHW), non-Hispanic Black (NHB), non-Hispanic other (NHO), and Hispanic.
Results: Our study included 528 patients, which included 79.2 % (n = 418) NHW, 7.0 % (n = 37) NHB, 3.6 % (n = 19) NHO, and 3.4 % (n = 18) Hispanic patients. Overall, 16.5 % of patients underwent RRM: 18.4 % of NHW, 10.8 % of NHB, 5.6 % of Hispanic (p = 0.45). For NHB and Hispanic patients, no individuals with HPMs (NHB 0/6, Hispanic 0/5) or MPMs (NHB 0/11, Hispanic 0/4) underwent RRM.
Conclusions: Our findings suggest that race and ethnicity may be associated with the decision to undergo RRM.
Keywords: BRCA; Breast cancer; Disparities; Genetic testing; Prophylactic mastectomy; Risk reducing mastectomy.
Copyright © 2025 Elsevier Inc. All rights reserved.